Toward whole-cell models for precision medicine and synthetic biology
Toward whole-cell models for precision medicine and synthetic biology
批准号:
9142821
负责人:
Jonathan Ross Karr
金额:
$42.38万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2021-06-30
关键词:
AccountingAddressAffectAlgorithmsBacteriaBasic ScienceBehaviorCell modelCell physiologyCellsCellular biologyComputer SimulationComputing MethodologiesDataDiseaseEducational workshopEngineeringGenesGenomeGenotypeGoalsGrowthHumanHuman BiologyMedicalMedicineMethodsModelingMolecularPathway interactionsPatientsPharmaceutical PreparationsPhenotypePhysiciansPhysicsRecruitment ActivityResearchResearch PersonnelScientistSoftware ToolsTechniquesTimeTrainingWorkbasedesignfrontiergene functionimprovedmodel buildingmodel designpersonalized medicineprecision medicineprotein expressionreaction ratesimulationsimulation softwaresynthetic biologytheoriestherapy designtool
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
My long-term goal is to develop comprehensive physics-based whole-cell computational models of humans and
bacteria to predict phenotypes from genotypes. Such models could help personalize therapy based on each
patient's 'omics profile and help predictably engineer bacteria to perform useful tasks such as producing drugs.
Despite decades of research and the growing wealth of data, we still do not understand how genotypes
influence phenotypes. For example, we do not quantitatively understand how protein expression is controlled or
how protein expression affects reaction rates, and, in turn, cellular behaviors such as growth. Consequently, we
cannot accurately predict how genes influence behavior, personalize therapy, or rationally engineer bacteria.
New computational methods are needed to combine our disparate data into a unified theory of cell biology.
Whole-cell modeling is a promising new technique that is capable of merging data into a single model that repre-
sents every molecular species and gene function. Whole-cell models can be constructed by combining multiple
pathway sub-models. Recently, my colleagues and I used this approach to achieve the first whole-cell model.
However, the model represents the simplest bacterium; the model does not account for numerous cell func-
tions; the model does not predict many phenotypes; and our simulation algorithm does not satisfy our core
sub-model time separation assumption. Furthermore, the model was time-consuming to construct; the model is
difficult to understand; the model is computationally expensive; and the simulation software is not reusable.
We must develop improved whole-cell modeling methods to facilitate complete whole-cell models and their
application to precision medicine, and to broadly enable researchers to engage in whole-cell modeling. (1) An
improved multi-algorithm simulation meta-algorithm is needed to rigorously simulate models. (2) A parallelized
simulator is needed to quickly simulate models. (3) New data curation and sub-model design tools are needed
to expedite model building. (4) New training materials and workshops are needed to recruit researchers into
whole-cell modeling.
My long-term goals are to develop personalized human whole-cell models, and to use these models to improve
medical therapy. Toward these goals, we will (1) develop improved whole-cell modeling methods to enable
more comprehensive models, (2) work toward the first human whole-cell model, (3) develop methods that use
personalized models to optimize therapy, and (4) develop whole-cell modeling training materials. These efforts
will address the methodological challenges of whole-modeling, expand the frontier of whole-cell modeling into
human biology and medicine, produce software tools which broadly enable researchers to simulate whole-cell
models, and advance the whole-cell modeling field. Looking forward, whole-cell models have the potential to
revolutionize basic science by providing scientists a complete understanding of cell biology, transform medicine
by enabling physicians to precisely design therapy, and enable synthetic biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Software tools for reproducibly building biomodels
-
批准号:10676067
-
项目类别:
-
资助金额:$39.54万
-
财政年份:2018
-
负责人:Jonathan Ross Karr
-
依托单位:
2016 Whole-Cell Modeling Summer School
-
批准号:9126053
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2016
-
负责人:Jonathan Ross Karr
-
依托单位:
海外基金